Arab A, et al. – Physicians designed this study to identify a panel of circulating microRNAs (c-miRNAs) in plasma that could contribute to early detection of non–small cell lung cancer (NSCLC). They suggested that considering the accessibility and stability of circulating miRNAs, plasma miR–141 is a useful biomarker early detection of NSCLC as a supplement in future screening studies.